Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Co-delivery of ibrutinib and hydroxychloroquine by albumin nanoparticles for enhanced chemotherapy of glioma
Zhihang Yang, Yufan Du, Lei Lei, et al.
International Journal of Pharmaceutics (2022) Vol. 630, pp. 122436-122436
Closed Access | Times Cited: 22

Showing 22 citing articles:

Autophagy inhibitors for cancer therapy: Small molecules and nanomedicines
Jianli Chen, Xuan Wu, Dan Yin, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108485-108485
Open Access | Times Cited: 43
Biodegradable Biopolymeric Nanoparticles for Biomedical Applications-Challenges and Future Outlook
Radhakrishnan Sreena, A. Joseph Nathanael
Materials (2023) Vol. 16, Iss. 6, pp. 2364-2364
Open Access | Times Cited: 30
Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood–brain barrier
Ya Wei, Xue Xia, Hanmei Li, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1713-1730
Closed Access | Times Cited: 23
Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment
Davide Frumento, Giancarlo Grossi, Marta Falesiedi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1398-1398
Open Access | Times Cited: 10
Tyrosine Kinase Inhibitors for Glioblastoma Multiforme: Challenges and Opportunities for Drug Delivery
Harpinder Kaur Brar, Jiney Jose, Zimei Wu, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 59-59
Open Access | Times Cited: 31
Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemia
Paras Famta, Saurabh Shah, Ganesh Vambhurkar, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 190, pp. 94-106
Closed Access | Times Cited: 20
Nanomedicine facilitated cell signaling blockade: difficulties and strategies to overcome glioblastoma
Mohammad Habeeb, Hariharan Thirumalai Vengateswaran, Huay Woon You, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 7, pp. 1677-1705
Closed Access | Times Cited: 8
Nano co-delivery of doxorubicin and plumbagin achieves synergistic chemotherapy of hepatocellular carcinoma
Chenyu Cao, Yifei Li, Fangzhou Shi, et al.
International Journal of Pharmaceutics (2024) Vol. 661, pp. 124424-124424
Closed Access | Times Cited: 7
Ibrutinib topical delivery for melanoma treatment: The effect of nanostructured lipid carriers’ composition on the controlled drug skin deposition
Lucas F. F. Albuquerque, Fernanda Vitelli Lins, Elizabete Cristina Iseke Bispo, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 237, pp. 113875-113875
Closed Access | Times Cited: 6
Material and Design Toolkit for Drug Delivery: State of the Art, Trends, and Challenges
Monireh Esmaeili Rad, Caner Soylukan, Prabir Kumar Kulabhusan, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 48, pp. 55201-55231
Closed Access | Times Cited: 11
Drug repurposing-based nanoplatform via modulating autophagy to enhance chemo-phototherapy against colorectal cancer
Ke Ding, Hailong Tian, Lei Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Development of Carvedilol-Loaded Albumin-Based Nanoparticles with Factorial Design to Optimize In Vitro and In Vivo Performance
Mohamed S. Attia, Mohamed F. Radwan, Tarek S. Ibrahim, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1425-1425
Open Access | Times Cited: 10
Local delivery of ibrutinib by folate receptor-mediated targeting PLGA-PEG nanoparticles to glioblastoma multiform: in vitro and in vivo studies
Bahar Morshedi, Mehdi Esfandyari‐Manesh, Fatemeh Atyabi, et al.
Journal of drug targeting (2025), pp. 1-16
Closed Access
Covalent inhibitors possessing autophagy-modulating capabilities: charting novel avenues in drug design and discovery
Yutong Wang, Shiyu Luo, Hongbao Sun, et al.
Drug Discovery Today (2025), pp. 104347-104347
Closed Access
Albumin-based nanoparticles: a potential and emerging oral drug delivery system
Yanping Sun, Huijia Song, Shuo Li, et al.
Drug Development and Industrial Pharmacy (2025), pp. 1-29
Closed Access
Latest Delivery Advancements of Lipid Nanoparticles for Cancer Treatment
Somia Chauhan, Kalpana Nagpal
Assay and Drug Development Technologies (2024) Vol. 22, Iss. 6, pp. 340-360
Closed Access | Times Cited: 3
Intranasal Carrier-Free Nanomodulator Addresses Both Symptomatology and Etiology of Alzheimer’s Disease by Restoring Neuron Plasticity and Reprogramming Lesion Microenvironment
Wenqin Yang, Yulong Shi, Yiwei Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 43, pp. 29779-29793
Closed Access | Times Cited: 3
Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade
Mahitab Bayoumi, John Youshia, Mona G. Arafa, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Closed Access | Times Cited: 2
Development and Validation of a Chromatographic Method for Ibrutinib Determination in Human and Porcine Skin
Lucas F. F. Albuquerque, Maria Victoria Souto, Felipe Saldanha‐Araújo, et al.
Chemistry (2024) Vol. 6, Iss. 2, pp. 272-282
Open Access | Times Cited: 2
Unleashing the Potential of Ibrutinib-Loaded Nanoparticles for Cancer Treatment—A Comprehensive Review
Razieh Behzadmehr, Sonia Fathi‐karkan, Sobia Razzaq, et al.
BioNanoScience (2024) Vol. 14, Iss. 3, pp. 3784-3797
Closed Access | Times Cited: 1
A facile carrier-free co-assembly nanoplatform for effective enhanced oral chemotherapy
MengYing Lei, Qing Chen, Yang Wang, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 95, pp. 105651-105651
Closed Access
Precious Cargo: The Role of Polymeric Nanoparticles in the Delivery of Covalent Drugs
Daniel Weissberger, Martina H. Stenzel, Luke Hunter
Molecules (2024) Vol. 29, Iss. 20, pp. 4949-4949
Open Access
Page 1

Scroll to top